25/11/2025
Thank you - always good to have more options.
・・・
Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone) is now available again on prescription in the UK! It was discontinued for several years but it is now back and another option for postmenopausal women.
Angeliq® is a combined hormone replacement therapy (HRT) and it contains Oestradiol and Drospirenone.
Drospirenone is a non-androgen progestogen which can be a good option for women who struggle to find a suitable progestogen, in particular when progestogens cause mood side effects or skin problems.
According to the manufacturer (Bayer):
Angeliq® is approved as:
✅Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women more than 1 year post menopause.
✅Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
Since it contains Oestradiol and is taken orally, there is a small increased risk of blood clots, stroke or DVT associated with it.
Menopausal Hormone Therapy needs to be prescribed individual to each woman, taken her clinical needs, past medical history, symptoms, side effects and potential risks into account.
It is always great to be able to offer more options and this is a great addition to our portfolio of treatment options to support post menopausal women.
